Combined differential gene expression profile and pathway enrichment analyses to elucidate the molecular mechanisms of uterine leiomyoma after gonadotropin-releasing hormone treatment

Huei Wen Chen, Jim C C Liu, Jeremy J W Chen, Yee Ming Lee, Jiann-Loung Hwang, Chii Ruey Tzeng

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Composite regulatory signature database (CRSD), a self-developed comprehensive Web server for composite regulatory signature discovery, used to compare the published microarray data with our data on patients with uterine leiomyoma treated with or without GnRH analogue (GnRH-a), revealed that the focal adhesion, mitogen-activated protein kinase (MAPK), CXC chemokine receptor 4/stromal-derived factor-1 (CXCR4/SDF-1), T-cell receptor, integrin, vascular endothelial growth factor (VEGF), GnRH, and transforming growth factor-β (TGF-β) signaling pathways are highly expressed in uterine leiomyoma and significantly down-regulated after GnRH-a treatment. According to the results these signaling pathways could be involved in inflammation, proliferation, and remodeling processes of leiomyoma development and possibly in the regression of leiomyoma after GnRH-a treatment, which might improve our understanding of the mechanisms of leiomyoma formation and help us to find novel drug targets or specific markers for diagnosis and prognosis in uterine leiomyoma.

Original languageEnglish
Pages (from-to)1219-1225
Number of pages7
JournalFertility and Sterility
Volume90
Issue number4
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Leiomyoma
Transcriptome
Gonadotropin-Releasing Hormone
Therapeutics
CXCR4 Receptors
Focal Adhesions
Transforming Growth Factors
T-Cell Antigen Receptor
Mitogen-Activated Protein Kinases
Integrins
Vascular Endothelial Growth Factor A
Databases
Inflammation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Combined differential gene expression profile and pathway enrichment analyses to elucidate the molecular mechanisms of uterine leiomyoma after gonadotropin-releasing hormone treatment. / Chen, Huei Wen; Liu, Jim C C; Chen, Jeremy J W; Lee, Yee Ming; Hwang, Jiann-Loung; Tzeng, Chii Ruey.

In: Fertility and Sterility, Vol. 90, No. 4, 10.2008, p. 1219-1225.

Research output: Contribution to journalArticle

@article{9c4d37e30f6f4d94823b44e44c7ab4fa,
title = "Combined differential gene expression profile and pathway enrichment analyses to elucidate the molecular mechanisms of uterine leiomyoma after gonadotropin-releasing hormone treatment",
abstract = "Composite regulatory signature database (CRSD), a self-developed comprehensive Web server for composite regulatory signature discovery, used to compare the published microarray data with our data on patients with uterine leiomyoma treated with or without GnRH analogue (GnRH-a), revealed that the focal adhesion, mitogen-activated protein kinase (MAPK), CXC chemokine receptor 4/stromal-derived factor-1 (CXCR4/SDF-1), T-cell receptor, integrin, vascular endothelial growth factor (VEGF), GnRH, and transforming growth factor-β (TGF-β) signaling pathways are highly expressed in uterine leiomyoma and significantly down-regulated after GnRH-a treatment. According to the results these signaling pathways could be involved in inflammation, proliferation, and remodeling processes of leiomyoma development and possibly in the regression of leiomyoma after GnRH-a treatment, which might improve our understanding of the mechanisms of leiomyoma formation and help us to find novel drug targets or specific markers for diagnosis and prognosis in uterine leiomyoma.",
author = "Chen, {Huei Wen} and Liu, {Jim C C} and Chen, {Jeremy J W} and Lee, {Yee Ming} and Jiann-Loung Hwang and Tzeng, {Chii Ruey}",
year = "2008",
month = "10",
doi = "10.1016/j.fertnstert.2007.11.015",
language = "English",
volume = "90",
pages = "1219--1225",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Combined differential gene expression profile and pathway enrichment analyses to elucidate the molecular mechanisms of uterine leiomyoma after gonadotropin-releasing hormone treatment

AU - Chen, Huei Wen

AU - Liu, Jim C C

AU - Chen, Jeremy J W

AU - Lee, Yee Ming

AU - Hwang, Jiann-Loung

AU - Tzeng, Chii Ruey

PY - 2008/10

Y1 - 2008/10

N2 - Composite regulatory signature database (CRSD), a self-developed comprehensive Web server for composite regulatory signature discovery, used to compare the published microarray data with our data on patients with uterine leiomyoma treated with or without GnRH analogue (GnRH-a), revealed that the focal adhesion, mitogen-activated protein kinase (MAPK), CXC chemokine receptor 4/stromal-derived factor-1 (CXCR4/SDF-1), T-cell receptor, integrin, vascular endothelial growth factor (VEGF), GnRH, and transforming growth factor-β (TGF-β) signaling pathways are highly expressed in uterine leiomyoma and significantly down-regulated after GnRH-a treatment. According to the results these signaling pathways could be involved in inflammation, proliferation, and remodeling processes of leiomyoma development and possibly in the regression of leiomyoma after GnRH-a treatment, which might improve our understanding of the mechanisms of leiomyoma formation and help us to find novel drug targets or specific markers for diagnosis and prognosis in uterine leiomyoma.

AB - Composite regulatory signature database (CRSD), a self-developed comprehensive Web server for composite regulatory signature discovery, used to compare the published microarray data with our data on patients with uterine leiomyoma treated with or without GnRH analogue (GnRH-a), revealed that the focal adhesion, mitogen-activated protein kinase (MAPK), CXC chemokine receptor 4/stromal-derived factor-1 (CXCR4/SDF-1), T-cell receptor, integrin, vascular endothelial growth factor (VEGF), GnRH, and transforming growth factor-β (TGF-β) signaling pathways are highly expressed in uterine leiomyoma and significantly down-regulated after GnRH-a treatment. According to the results these signaling pathways could be involved in inflammation, proliferation, and remodeling processes of leiomyoma development and possibly in the regression of leiomyoma after GnRH-a treatment, which might improve our understanding of the mechanisms of leiomyoma formation and help us to find novel drug targets or specific markers for diagnosis and prognosis in uterine leiomyoma.

UR - http://www.scopus.com/inward/record.url?scp=52949141900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949141900&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2007.11.015

DO - 10.1016/j.fertnstert.2007.11.015

M3 - Article

C2 - 18258233

AN - SCOPUS:52949141900

VL - 90

SP - 1219

EP - 1225

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -